0 Commentarios
0 Acciones
862 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Noticias Feed
- EXPLORE
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Foros
-
Please log in to like, share and comment!
-
Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Detailed Analysis of Executive Summary Biosimilar Market Size and Share The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Global Executive Summary Biosimilar Market: Size, Share, and Forecast The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of chronic...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Global Executive Summary Biosimilar Market: Size, Share, and Forecast The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of chronic...0 Commentarios 0 Acciones 486 Views 0 Vista previa
-
Biosimilar Monoclonal Antibodies Market Share Rises as Healthcare Costs DeclineThe global Biosimilar Monoclonal Antibodies Market was valued at USD 14.92 billion in 2024 and is projected to grow from USD 17.35 billion in 2025 to USD 58.07 billion by 2033, registering a robust CAGR of 16.3% during the forecast period (2025–2033). The market is witnessing remarkable expansion as healthcare systems worldwide increasingly adopt cost-effective biologic alternatives to...0 Commentarios 0 Acciones 11 Views 0 Vista previa
Patrocinados
Patrocinados